Status and phase
Conditions
Treatments
About
To investigate the safety, tolerability and pharmacokinetic characteristics of LC28-0126 in healthy male subjects
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
89 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal